Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

The Value of Serum CA19-9 Levels in predicting Extent of Hepatic Fibrosis in Patients with Chronic Hepatitis B.

Haque MS, Sultana S, Mahtab MA, Al-Mamun A, Rahman S.

Euroasian J Hepatogastroenterol. 2015 Jan-Jun;5(1):16-18. doi: 10.5005/jp-journals-10018-1122. Epub 2015 Jan 6.

2.

Chemoprotective effect of omega-3 fatty acids on thioacetamide induced hepatic fibrosis in male rats.

Al-Attar AM, Al-Rethea HA.

Saudi J Biol Sci. 2017 May;24(4):956-965. doi: 10.1016/j.sjbs.2016.01.029. Epub 2016 Jan 21.

3.

Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India.

Kumar A, Khan NM, Anikhindi SA, Sharma P, Bansal N, Singla V, Arora A.

World J Gastroenterol. 2017 Jan 28;23(4):687-696. doi: 10.3748/wjg.v23.i4.687.

4.

Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride.

Li Y, Shi Y, Sun Y, Liu L, Bai X, Wang D, Li H.

Mol Med Rep. 2017 Jan;15(1):47-56. doi: 10.3892/mmr.2016.5965. Epub 2016 Nov 24.

5.

Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?

Seo W, Jeong WI.

World J Gastroenterol. 2016 Jan 28;22(4):1348-56. doi: 10.3748/wjg.v22.i4.1348. Review.

6.

Diffusion-weighted MRI for the assessment of liver fibrosis: principles and applications.

Palmucci S, Cappello G, Attinà G, Fuccio Sanzà G, Foti PV, Ettorre GC, Milone P.

Biomed Res Int. 2015;2015:874201. doi: 10.1155/2015/874201. Epub 2015 Mar 19. Review.

7.

Yin-Chen-Hao-Tang alleviates biliary obstructive cirrhosis in rats by inhibiting biliary epithelial cell proliferation and activation.

Wang B, Sun MY, Long AH, Cao HY, Ren S, Bian YQ, Lu X, Gu HT, Liu CH, Liu P.

Pharmacogn Mag. 2015 Apr-Jun;11(42):417-25. doi: 10.4103/0973-1296.153098.

8.

Age and ethnicity in cirrhosis.

Sajja KC, Mohan DP, Rockey DC.

J Investig Med. 2014 Oct;62(7):920-6. doi: 10.1097/JIM.0000000000000106.

9.

A boswellic acid-containing extract ameliorates schistosomiasis liver granuloma and fibrosis through regulating NF-κB signaling in mice.

Liu M, Wu Q, Chen P, Büchele B, Bian M, Dong S, Huang D, Ren C, Zhang Y, Hou X, Simmet T, Shen J.

PLoS One. 2014 Jun 18;9(6):e100129. doi: 10.1371/journal.pone.0100129. eCollection 2014.

10.

Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease.

Traber PG, Chou H, Zomer E, Hong F, Klyosov A, Fiel MI, Friedman SL.

PLoS One. 2013 Oct 9;8(10):e75361. doi: 10.1371/journal.pone.0075361. eCollection 2013.

11.

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection.

Lamontagne A, Long RE, Comunale MA, Hafner J, Rodemich-Betesh L, Wang M, Marrero J, Di Bisceglie AM, Block T, Mehta A.

PLoS One. 2013 Jun 4;8(6):e64992. doi: 10.1371/journal.pone.0064992. Print 2013.

12.

Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats.

Xie H, Tao Y, Lv J, Liu P, Liu C.

Evid Based Complement Alternat Med. 2013;2013:972863. doi: 10.1155/2013/972863. Epub 2013 Jan 29.

13.

Huangqi decoction inhibits apoptosis and fibrosis, but promotes Kupffer cell activation in dimethylnitrosamine-induced rat liver fibrosis.

Liu C, Wang G, Chen G, Mu Y, Zhang L, Hu X, Sun M, Liu C, Liu P.

BMC Complement Altern Med. 2012 Apr 24;12:51. doi: 10.1186/1472-6882-12-51.

14.

Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways.

Marquardt JU, Seo D, Gómez-Quiroz LE, Uchida K, Gillen MC, Kitade M, Kaposi-Novak P, Conner EA, Factor VM, Thorgeirsson SS.

Biochim Biophys Acta. 2012 Jun;1822(6):942-51. doi: 10.1016/j.bbadis.2012.02.012. Epub 2012 Feb 22.

15.

The function of integrin-linked kinase in normal and activated stellate cells: implications for fibrogenesis in wound healing.

Shafiei MS, Rockey DC.

Lab Invest. 2012 Feb;92(2):305-16. doi: 10.1038/labinvest.2011.155. Epub 2011 Nov 7.

16.

Sparse logistic regression for diagnosis of liver fibrosis in rat by using SCAD-penalized likelihood.

Yan FR, Lin JG, Liu Y.

J Biomed Biotechnol. 2011;2011:875309. doi: 10.1155/2011/875309. Epub 2011 Jun 1.

17.

Adiponectin regulation of stellate cell activation via PPARγ-dependent and -independent mechanisms.

Shafiei MS, Shetty S, Scherer PE, Rockey DC.

Am J Pathol. 2011 Jun;178(6):2690-9. doi: 10.1016/j.ajpath.2011.02.035.

18.

Tumor necrosis factor α stimulates endothelin-1 synthesis in rat hepatic stellate cells in hepatic wound healing through a novel IKK/JNK pathway.

Zhan S, Rockey DC.

Exp Cell Res. 2011 Apr 15;317(7):1040-8. doi: 10.1016/j.yexcr.2010.12.026. Epub 2011 Jan 7.

19.

CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.

Hintermann E, Bayer M, Pfeilschifter JM, Luster AD, Christen U.

J Autoimmun. 2010 Dec;35(4):424-35. doi: 10.1016/j.jaut.2010.09.003. Epub 2010 Oct 6.

20.

Pathogenesis of non-alcoholic fatty liver disease.

Dowman JK, Tomlinson JW, Newsome PN.

QJM. 2010 Feb;103(2):71-83. doi: 10.1093/qjmed/hcp158. Epub 2009 Nov 13. Review. No abstract available.

Supplemental Content

Support Center